Tariff clouds loom large! Barclays names the "pressure-resistant king" and "disaster area" in the US medical device industry

Barclays Bank analyzed the impact of the new tariff policy of the Trump administration on the medical device industry in its research report. The report pointed out that Abbott and Baxter International will be the least affected companies, while Johnson & Johnson and Medtronic will be the most affected. Among large medical technology companies, Abbott, Baxter International, Edwards Lifesciences, and Intuitive Surgical were rated as "buy," while Zimmer Biomet Holdings was rated as "sell." Small and mid-cap stocks such as Globus Medical, AlphaTek, and Tandem Diabetes Care are also less affected. In contrast, companies like Becton Dickinson, InMode, and Medtronic face significant tariff risks